Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment.

Kulasekararaj AG, Lee JW, Patriquin CJ, Piatek CI, Röth A, Barcellini W, Brodsky RA, Nishimura JI, Yu J, Mahdi M, Peffault de Latour R

Open source

DOI: 10.1182/bloodadvances.2024015490
Published: 2025 Oct 14
Container: Blood advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2024015490,
  title = {Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment.},
  author = {Kulasekararaj AG and Lee JW and Patriquin CJ and Piatek CI and Röth A and Barcellini W and Brodsky RA and Nishimura JI and Yu J and Mahdi M and Peffault de Latour R},
  year = {2025},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2024015490},
  url = {https://doi.org/10.1182/bloodadvances.2024015490}
}

RIS

TY  - JOUR
TI  - Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment.
AU  - Kulasekararaj AG
AU  - Lee JW
AU  - Patriquin CJ
AU  - Piatek CI
AU  - Röth A
AU  - Barcellini W
AU  - Brodsky RA
AU  - Nishimura JI
AU  - Yu J
AU  - Mahdi M
AU  - Peffault de Latour R
PY  - 2025
JO  - Blood advances
DO  - 10.1182/bloodadvances.2024015490
UR  - https://doi.org/10.1182/bloodadvances.2024015490
ER  -

APA

AG, K., JW, L., CJ, P., CI, P., A, R., W, B., RA, B., JI, N., J, Y., M, M., & R, P. D. L. (2025). Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment.. Blood advances. https://doi.org/10.1182/bloodadvances.2024015490

Source records

pubmed · retrieved 2026-09-26T23:58:32.239Z